drugset / Trial / NCT00479258
Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the safety and efficacy of Exubera on pulmonary function and glycemic control in subjects ages 6-17 over a 1 year period.
Timeline
- Start
- 2007-10
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulin | Protein / enzyme biologic | — | Inhaled |
| Comparator | Insulin | Protein / enzyme biologic | — | Subcutaneous |